InsiderTrades

Form 4 for TVTX Travere Therapeutics, Inc.

Accepted 2024-10-04 00:00:00 ET · period of report 2024-10-04 · accession 0001415889-24-024795 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2024-10-04 2024-10-04 TVTX LYONS GARY A Dir S - Sale+OE $14.73 -40.0K 69.8K -36% -$589.1K
D 2024-10-04 2024-10-04 TVTX LYONS GARY A Dir M - OptEx $10.48 +40.0K 91.0K +78% +$419.2K
D 2024-10-04 2024-10-04 TVTX LYONS GARY A Dir M - OptEx $0.00 +40.0K 0 New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-10-04 S D 18,821 $15.15 51,000 D — — (F3) The weighted average sale price for the transaction reported was $15.1547, and the range of prices were between $14.92 and $15.44. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.
2 Common Common Stock 2024-10-04 M A 40,000 $10.48 91,000 D — —
3 Common Common Stock 2024-10-04 S D 21,179 $14.35 69,821 D — — (F2) The weighted average sale price for the transaction reported was $14.3479, and the range of prices were between $13.92 and $14.91. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.
4 Derivative Stock option (right to buy) 2024-10-04 M A 40,000 $0.00 0 D $10.48 · — to 2024-10-08 40,000 Common Stock (F4) The stock option is fully vested and exercisable.